JFS Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4
Closed -$35 1937
2025
Q2
$35 Sell
4
-91
-96% -$660 ﹤0.01% 1843
2025
Q1
$757 Buy
95
+88
+1,257% +$890 ﹤0.01% 1702
2024
Q4
$64 Hold
7
﹤0.01% 1903
2024
Q3
$65 Sell
7
-15
-68% -$124 ﹤0.01% 1921
2024
Q2
$216 Sell
22
-47
-68% -$573 ﹤0.01% 1890
2024
Q1
$1.04K Hold
69
﹤0.01% 1650
2023
Q4
$1.49K Buy
69
+60
+667% +$1.11K ﹤0.01% 1537
2023
Q3
$168 Sell
9
-29
-76% -$677 ﹤0.01% 1880
2023
Q2
$963 Sell
38
-15
-28% -$378 ﹤0.01% 1620
2023
Q1
$1.37K Buy
53
+6
+13% +$161 ﹤0.01% 1497
2022
Q4
$1.11K Hold
47
﹤0.01% 1572
2022
Q3
$1K Sell
47
-17
-27% -$596 ﹤0.01% 1654
2022
Q2
$2K Buy
64
+38
+146% +$1.61K ﹤0.01% 1390
2022
Q1
$2K Buy
26
+4
+18% +$288 ﹤0.01% 1501
2021
Q4
$2K Sell
22
-34
-61% -$4.06K ﹤0.01% 1168
2021
Q3
$7K Buy
56
+50
+833% +$7.28K ﹤0.01% 691
2021
Q2
$1K Hold
6
﹤0.01% 584
2021
Q1
$1K Hold
6
﹤0.01% 576
2020
Q4
$1K Buy
6
+3
+100% +$610 ﹤0.01% 563
2020
Q3
$1K Buy
+3
New +$635 ﹤0.01% 545

Other funds holding TDOC

JFS Wealth Advisors's TDOC Position: Q3 2025 in Review

JFS Wealth Advisors sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 4 shares — an estimated $35 sold.

JFS Wealth Advisors first reported a position in TDOC in Q3 2020 and held it in 20 quarters. The position peaked at $7K in Q3 2021. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • JFS Wealth Advisors reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • JFS Wealth Advisors sold 4 Teladoc Health shares in Q3 2025, an estimated $35.
  • JFS Wealth Advisors first reported a position in Teladoc Health in Q3 2020 and held it in 20 quarters.
  • JFS Wealth Advisors's Teladoc Health position peaked at $7K in Q3 2021.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on JFS Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.